Aadi Bioscience News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

20.12.24	Why Is Cancer-Focused Aadi Bioscience Stock Trading Higher On Friday? (Benzinga)
05.11.24	Ausblick: Aadi Bioscience präsentiert Bilanzzahlen zum jüngsten Jahresviertel (finanzen.net)
25.08.24	Weekly Biotech Buzz: AADI Trims R&D Jobs, JNJ Loosens Purse Strings, FDA Snubs REGN's Myeloma Drug (RTTNews)
21.08.24	Cancer Focused-Aadi Bioscience Stock Plunges As Solid Tumor Trial Falls Short Of Expectations (Benzinga)
06.08.24	Ausblick: Aadi Bioscience präsentiert das Zahlenwerk zum abgelaufenen Jahresviertel (finanzen.net)
07.05.24	Ausblick: Aadi Bioscience öffnet die Bücher zum abgelaufenen Quartal (finanzen.net)
12.03.24	Aadi Bioscience Earnings Preview (Benzinga)
12.03.24	Ausblick: Aadi Bioscience stellt Zahlen zum jüngsten Quartal vor (finanzen.net)
14.12.23	Aadi Bioscience Reports Interim Results from PRECISION1 Trial of nab-Sirolimus Demonstrating Anti-Tumor Activity in Solid Tumors with TSC1 or TSC2 Inactivating Alterations (PR Newswire)
08.11.23	Aadi Bioscience Q3 Loss Per Share Narrows (RTTNews)
08.11.23	Aadi Bioscience Reports Financial Results for the Third Quarter 2023 and Provides Corporate Update (PR Newswire)
07.11.23	Ausblick: Aadi Bioscience präsentiert das Zahlenwerk zum abgelaufenen Jahresviertel (finanzen.net)
06.11.23	Aadi Bioscience to Participate in Jefferies London Healthcare Conference (PR Newswire)
01.11.23	Aadi Bioscience to Report Third Quarter 2023 Results and Operational Update (PR Newswire)
19.10.23	Aadi Bioscience Announces Poster Presentations on Nab-Sirolimus at the International Gynecologic Cancer Society (IGCS) 2023 Annual Global Meeting (PR Newswire)
12.10.23	Aadi Bioscience Announces Poster Presentations at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics (PR Newswire)
05.10.23	Aadi Bioscience Announces Poster Presentations at the North American Neuroendocrine Tumor Society (NANETS) 2023 Multidisciplinary NET Medical Symposium (PR Newswire)
03.10.23	Aadi Bioscience Grants New CEO Dave Lennon, Ph.D. Inducement Award Under Nasdaq Listing Rule 5635 (c)(4) (PR Newswire)
02.10.23	Aadi Bioscience Names Dave Lennon President, CEO; Scott Giacobello To Continue As CFO (RTTNews)
02.10.23	Aadi Bioscience Appoints Dave Lennon, Ph.D. as President and Chief Executive Officer (PR Newswire)
20.09.23	Aadi Bioscience Announces Poster Presentations at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics (PR Newswire)
05.09.23	Aadi Bioscience to Participate at Upcoming Investor Conferences (PR Newswire)
09.08.23	Aadi Bioscience Announces Financial Results for the Second Quarter 2023 and Provides Corporate Update (PR Newswire)
08.08.23	Ausblick: Aadi Bioscience präsentiert Quartalsergebnisse (finanzen.net)
02.08.23	Aadi Bioscience to Report Second Quarter 2023 Results and Operational Update (PR Newswire)
25.05.23	Aadi Bioscience Announces Presentations at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting (PR Newswire)
23.05.23	Aadi Bioscience to Participate in Upcoming Investor Events (PR Newswire)
10.05.23	Aadi Bioscience Announces Financial Results and Operational Update for the First Quarter 2023 and Provides Update on PRECISION 1 Tumor Agnostic Trial (PR Newswire)
26.04.23	Aadi Bioscience Announces Multiple Presentations on nab-Sirolimus at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting (PR Newswire)
14.04.23	Aadi Bioscience to Present Multiple Posters on nab-Sirolimus at the 2023 American Association for Cancer Research (AACR) Annual Meeting (PR Newswire)
06.04.23	Aadi Bioscience to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2023 (PR Newswire)
28.03.23	Aadi Bioscience Announces Financial Results for the Fourth Quarter and Full-Year 2022 and Provides Corporate Update (PR Newswire)
27.03.23	Aadi Bioscience Appoints Mohammad Hirmand, M.D. to Board of Directors (PR Newswire)
26.03.23	Aadi Bioscience Presents Clinical Data from PRECISION 1 and AMPECT Trials at the Society of Gynecological Oncology (SGO) Annual Meeting on Women's Cancer (PR Newswire)
15.03.23	Aadi Bioscience to Report Fourth Quarter and Full-Year 2022 Results and Corporate Update (PR Newswire)
03.03.23	Aadi Bioscience Announces Leadership Transition (PR Newswire)
22.02.23	Aadi Bioscience to Present at the 43rd Annual Cowen Healthcare Conference (PR Newswire)
17.11.22	Aadi Bioscience Presents PRECISION 1 Trial in Progress Poster and AMPECT Trial Final Analysis at the Connective Tissue Oncology Society (CTOS) 2022 Annual Meeting (PR Newswire)
09.11.22	Aadi Bioscience Announces Financial Results for the Third Quarter of 2022 and Provides Corporate Update (PR Newswire)
08.11.22	Aadi Bioscience Announces Planned Leadership Transition (PR Newswire)
03.11.22	Aadi Bioscience to Present at Upcoming Investor Conferences (PR Newswire)
27.10.22	Aadi Bioscience Announces Improved Anti-Tumor Activity of KRAS Inhibitors in Combination with Nab-sirolimus at the 34th EORTC-NCI-AACR Symposium (PR Newswire)
12.10.22	Mirati, Aadi To Evaluate Adagrasib, Nab-sirolimus Combination To Treat NSCLC, Other Solid Tumors (RTTNews)
12.10.22	Aadi Bioscience Announces Improved Anti-Tumor Activity of KRAS Inhibitors in Combination with Nab-sirolimus at the 34th EORTC-NCI-AACR Symposium (PR Newswire)
12.10.22	Mirati Therapeutics and Aadi Bioscience Partner to Evaluate the Combination of Adagrasib with Nab-sirolimus in Patients with Advanced Non-Small Cell Lung Cancer and Other Solid Tumors with a KRAS[... (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Aadi Bioscience Inc Registered Shs

Aktien Top/Flop

Meistgelesene Nachrichten